NCT06775288Active, not recruiting
Hypoglycemia Prevention and Awareness Program
Effect of Hypoglycemia Prevention and Awareness Program (HypoPAP) on Patient Outcomes: Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 15 Jan 2025
Brief summary (registry, in English)
The aim of this project is to examine the effects of the Hypoglycemia Prevention and Awareness Program (HypoPAP) on patient outcomes, including metabolic, psychological, social, and economic parameters, in individuals with type 2 diabetes and impaired hypoglycemia awareness. Through the interventions provided to participants, the study aims to achieve the following improvements: * Physiological parameters: Enhanced glycemic control, reduced hypoglycemia frequency, improved hypoglycemia awareness, and optimized HbA1c levels. * Psychological parameters: Reduced fear of hypoglycemia, increased hypoglycemic confidence, and improved attitudes toward hypoglycemia management. * Social parameters: Decreased social withdrawal due to fear of hypoglycemia, as assessed through relevant items in validated scales. * Economic parameters: Reduced frequency of hospitalizations and emergency department visits. Overall, the program seeks to enhance participants' ability to prevent and manage hypoglycemia, thereby improving their overall well-being.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 62 (estimated)
- First submitted
- 4 Jan 2025
- Start date
- 1 Nov 2024
- Primary completion date
- 15 Dec 2024
- Lead sponsor
- Merve DerviAYoAYlu
- Diseases
- Type 2 diabetes
- NCT number
- NCT06775288
What you commit to
- Study type: Interventional
- Planned participants: 62
- From 1 Nov 2024 to the primary completion date, 15 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Having visual, auditory, cognitive impairment
- Having a condition that prevents communication
- Having chronic renal failure, chronic vascular disease, chronic liver disease, cancer
- Endocrine and eating disorders
Other
- Not being able to use information technology products
- Pregnancy
- Individuals who do not agree to participate in the study
- Do not meet the inclusion criteria will not be included.
Who the study is looking for
- Being 18 years of age and older
- Being able to communicate in Turkish
- Being diagnosed with type 2 diabetes
- Having used insulin for at least one year
- Having reduced hypoglycemia awareness
- Being willing to participate in the study
- Having and being able to use information technology products (telephone, computer).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dokuz Eylul University Coordinator of this site? Confirm its status | Izmir | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.